BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 37284203)

  • 41. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biliary Strictures and Cholangiocarcinoma - Untangling a Diagnostic Conundrum.
    Ney A; Garcia-Sampedro A; Goodchild G; Acedo P; Fusai G; Pereira SP
    Front Oncol; 2021; 11():699401. PubMed ID: 34660269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.
    Klein AP
    Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):493-502. PubMed ID: 34002083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Tempero MA; Malafa MP; Al-Hawary M; Behrman SW; Benson AB; Cardin DB; Chiorean EG; Chung V; Czito B; Del Chiaro M; Dillhoff M; Donahue TR; Dotan E; Ferrone CR; Fountzilas C; Hardacre J; Hawkins WG; Klute K; Ko AH; Kunstman JW; LoConte N; Lowy AM; Moravek C; Nakakura EK; Narang AK; Obando J; Polanco PM; Reddy S; Reyngold M; Scaife C; Shen J; Vollmer C; Wolff RA; Wolpin BM; Lynn B; George GV
    J Natl Compr Canc Netw; 2021 Apr; 19(4):439-457. PubMed ID: 33845462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis.
    Wang X; Hu LP; Qin WT; Yang Q; Chen DY; Li Q; Zhou KX; Huang PQ; Xu CJ; Li J; Yao LL; Wang YH; Tian GA; Yang JY; Yang MW; Liu DJ; Sun YW; Jiang SH; Zhang XL; Zhang ZG
    Nat Commun; 2021 Jan; 12(1):174. PubMed ID: 33420030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Immune Nature of Platelets Revisited.
    Maouia A; Rebetz J; Kapur R; Semple JW
    Transfus Med Rev; 2020 Oct; 34(4):209-220. PubMed ID: 33051111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutrophil diversity and plasticity in tumour progression and therapy.
    Jaillon S; Ponzetta A; Di Mitri D; Santoni A; Bonecchi R; Mantovani A
    Nat Rev Cancer; 2020 Sep; 20(9):485-503. PubMed ID: 32694624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The development an artificial intelligence algorithm for early sepsis diagnosis in the intensive care unit.
    Yuan KC; Tsai LW; Lee KH; Cheng YW; Hsu SC; Lo YS; Chen RJ
    Int J Med Inform; 2020 Sep; 141():104176. PubMed ID: 32485555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis.
    Bullock AF; Greenley SL; McKenzie GAG; Paton LW; Johnson MJ
    Eur J Clin Nutr; 2020 Nov; 74(11):1519-1535. PubMed ID: 32366995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunotherapy for pancreatic cancer: A 2020 update.
    Schizas D; Charalampakis N; Kole C; Economopoulou P; Koustas E; Gkotsis E; Ziogas D; Psyrri A; Karamouzis MV
    Cancer Treat Rev; 2020 Jun; 86():102016. PubMed ID: 32247999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling.
    Nguyen DT; Lee E; Alimperti S; Norgard RJ; Wong A; Lee JJ; Eyckmans J; Stanger BZ; Chen CS
    Sci Adv; 2019 Aug; 5(8):eaav6789. PubMed ID: 31489365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Tumor Microenvironment Innately Modulates Cancer Progression.
    Hinshaw DC; Shevde LA
    Cancer Res; 2019 Sep; 79(18):4557-4566. PubMed ID: 31350295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Neutrophil Life Cycle.
    Hidalgo A; Chilvers ER; Summers C; Koenderman L
    Trends Immunol; 2019 Jul; 40(7):584-597. PubMed ID: 31153737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment.
    Looi CK; Chung FF; Leong CO; Wong SF; Rosli R; Mai CW
    J Exp Clin Cancer Res; 2019 Apr; 38(1):162. PubMed ID: 30987642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity.
    Padoan A; Plebani M; Basso D
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of coagulation and platelets in colon cancer-associated thrombosis.
    Mitrugno A; Tassi Yunga S; Sylman JL; Zilberman-Rudenko J; Shirai T; Hebert JF; Kayton R; Zhang Y; Nan X; Shatzel JJ; Esener S; Duvernay MT; Hamm HE; Gruber A; Williams CD; Takata Y; Armstrong R; Morgan TK; McCarty OJT
    Am J Physiol Cell Physiol; 2019 Feb; 316(2):C264-C273. PubMed ID: 30462538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of platelets and platelet receptors in cancer metastasis.
    Schlesinger M
    J Hematol Oncol; 2018 Oct; 11(1):125. PubMed ID: 30305116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of the human pancreas and its vasculature - An integrated review covering anatomical, embryological, histological, and molecular aspects.
    Henry BM; Skinningsrud B; Saganiak K; Pękala PA; Walocha JA; Tomaszewski KA
    Ann Anat; 2019 Jan; 221():115-124. PubMed ID: 30300687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nutrition Implications for Long-Term Survivors of Pancreatic Cancer Surgery.
    Petzel MQB; Hoffman L
    Nutr Clin Pract; 2017 Oct; 32(5):588-598. PubMed ID: 29927530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Platelet Lifeline to Cancer: Challenges and Opportunities.
    Haemmerle M; Stone RL; Menter DG; Afshar-Kharghan V; Sood AK
    Cancer Cell; 2018 Jun; 33(6):965-983. PubMed ID: 29657130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.